Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Pharmacology Research & Perspectives
|
May 5, 2025
Population pharmacokinetics and exposure-response relationship for temsavir following fostemsavir administration in treatment-experienced HIV patients
Ridhi Parasrampuria, Nilay Thakkar, Katy Moore, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
September 9, 2022
Pharmacokinetics, metabolism and excretion of radiolabeled fostemsavir administered with or without ritonavir in healthy male subjects
Peter Gorycki, Mindy Magee, Peter Ackerman, et al.
Clinical and Translational Science
|
February 7, 2020
Effects of Temsavir, Active Moiety of Antiretroviral Agent Fostemsavir, on QT Interval: Results From a Phase I Study and an Exposure-Response Analysis
Chakradhar Lagishetty, Katy Moore, Peter Ackerman, et al.
Journal of Pharmaceutical Sciences
|
November 4, 2023
A Quantitative Clinical Pharmacology-Based Framework For Model-Informed Vaccine Development
Rajat Desikan, Massimiliano Germani, Piet H van der Graaf, et al.
HIV Research & Clinical Practice
|
March 14, 2022
Evaluation of the pharmacokinetic drug-drug interaction between the antiretroviral agents fostemsavir and maraviroc: a single-sequence crossover study in healthy participants
Mary Beth Wire, Mindy Magee, Peter Ackerman, et al.
Infectious Diseases and Therapy
|
October 26, 2024
Correction to: Population Pharmacokinetics of Bepirovirsen in Healthy Participants and Participants with Chronic Hepatitis B Virus Infection: Results from Phase 1, 2a, and 2b Studies
Amir S Youssef, Mohamed Ismail, Kelong Han, et al.
Infectious Diseases and Therapy
|
May 25, 2024
Population Pharmacokinetics of Bepirovirsen in Healthy Participants and Participants with Chronic Hepatitis B Virus Infection: Results from Phase 1, 2a, and 2b Studies
Amir S Youssef, Mohamed Ismail, Kelong Han, et al.
Journal of Clinical Pharmacology
|
December 28, 2020
Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Temsavir, the Active Moiety of Fostemsavir
Mindy Magee, Jill Slater, Frank Mannino, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 11, 2025
A Step-by-Step Workflow for Performing In Silico Clinical Trials With Nonlinear Mixed Effects Models
Javiera Cortés-Ríos, Mindy Magee, Anna Sher, et al.
Pharmacology Research & Perspectives
|
July 11, 2024
No dose adjustment of metformin or substrates of organic cation transporters (OCT)1 and OCT2 and multidrug and toxin extrusion protein (MATE)1/2K with fostemsavir coadministration based on modeling approaches
Dung Nguyen, Xiusheng Miao, Kunal Taskar, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Pharmacology Research & Perspectives
|
May 5, 2025
Population pharmacokinetics and exposure-response relationship for temsavir following fostemsavir administration in treatment-experienced HIV patients
Ridhi Parasrampuria, Nilay Thakkar, Katy Moore, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
September 9, 2022
Pharmacokinetics, metabolism and excretion of radiolabeled fostemsavir administered with or without ritonavir in healthy male subjects
Peter Gorycki, Mindy Magee, Peter Ackerman, et al.
Clinical and Translational Science
|
February 7, 2020
Effects of Temsavir, Active Moiety of Antiretroviral Agent Fostemsavir, on QT Interval: Results From a Phase I Study and an Exposure-Response Analysis
Chakradhar Lagishetty, Katy Moore, Peter Ackerman, et al.
Journal of Pharmaceutical Sciences
|
November 4, 2023
A Quantitative Clinical Pharmacology-Based Framework For Model-Informed Vaccine Development
Rajat Desikan, Massimiliano Germani, Piet H van der Graaf, et al.
HIV Research & Clinical Practice
|
March 14, 2022
Evaluation of the pharmacokinetic drug-drug interaction between the antiretroviral agents fostemsavir and maraviroc: a single-sequence crossover study in healthy participants
Mary Beth Wire, Mindy Magee, Peter Ackerman, et al.
Infectious Diseases and Therapy
|
October 26, 2024
Correction to: Population Pharmacokinetics of Bepirovirsen in Healthy Participants and Participants with Chronic Hepatitis B Virus Infection: Results from Phase 1, 2a, and 2b Studies
Amir S Youssef, Mohamed Ismail, Kelong Han, et al.
Infectious Diseases and Therapy
|
May 25, 2024
Population Pharmacokinetics of Bepirovirsen in Healthy Participants and Participants with Chronic Hepatitis B Virus Infection: Results from Phase 1, 2a, and 2b Studies
Amir S Youssef, Mohamed Ismail, Kelong Han, et al.
Journal of Clinical Pharmacology
|
December 28, 2020
Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Temsavir, the Active Moiety of Fostemsavir
Mindy Magee, Jill Slater, Frank Mannino, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 11, 2025
A Step-by-Step Workflow for Performing In Silico Clinical Trials With Nonlinear Mixed Effects Models
Javiera Cortés-Ríos, Mindy Magee, Anna Sher, et al.
Pharmacology Research & Perspectives
|
July 11, 2024
No dose adjustment of metformin or substrates of organic cation transporters (OCT)1 and OCT2 and multidrug and toxin extrusion protein (MATE)1/2K with fostemsavir coadministration based on modeling approaches
Dung Nguyen, Xiusheng Miao, Kunal Taskar, et al.
Page
of 3